Search

Blauvelt, Andrew, Alexa B Kimball, Matthias Augustin, Yukari Okubo, Michael M Witte, Claudia Rodriguez Capriles, Angelina Sontag, Vipin Arora, Olawale Osuntokun, and Bruce Strober. 2022. “Efficacy and Safety of Mirikizumab in Psoriasis: Results from a 52-Week, Double-Blind, Placebo-Controlled, Randomized Withdrawal, Phase III Trial (OASIS-1).”. The British Journal of Dermatology 187 (6): 866-77.

Kumar, Sandeep, Kelsey Flood, Nicole M Golbari, Alexandra P Charrow, Martina L Porter, and Alexa B Kimball. 2021. “Psoriasis: Knowledge, Attitudes and Perceptions Among Primary Care Providers.”. Journal of the American Academy of Dermatology 84 (5): 1421-23.

Golbari, N M, S J Lockwood, M L Porter, and A B Kimball. 2018. “Assessment of Treatment-Seeking Behaviour in Patients With Psoriasis.”. The British Journal of Dermatology 179 (4): 989-90.

Papp, K A, A Blauvelt, A B Kimball, C Han, B Randazzo, Y Wasfi, Y-K Shen, S Li, and C E M Griffiths. 2018. “Patient-Reported Symptoms and Signs of Moderate-to-Severe Psoriasis Treated With Guselkumab or Adalimumab: Results from the Randomized VOYAGE 1 Trial.”. Journal of the European Academy of Dermatology and Venereology : JEADV 32 (9): 1515-22.

Griffiths, Christopher E M, Kim A Papp, Alexa B Kimball, Bruce Randazzo, Michael Song, Shu Li, Yaung-Kaung Shen, and Andrew Blauvelt. 2018. “Long-Term Efficacy of Guselkumab for the Treatment of Moderate-to-Severe Psoriasis: Results from the Phase 3 VOYAGE 1 Trial Through Two Years.”. Journal of Drugs in Dermatology : JDD 17 (8): 826-32.

Zachariae, Claus, Kenneth Gordon, Alexandra B Kimball, Mark Lebwohl, Andrew Blauvelt, Craig Leonardi, Daniel Braun, Missy McKean-Matthews, Russel Burge, and Gregory Cameron. 2018. “Efficacy and Safety of Ixekizumab over 4 years of Open-Label Treatment in a Phase 2 Study in Chronic Plaque Psoriasis.”. Journal of the American Academy of Dermatology 79 (2): 294-301.e6.

Gibson, R S, and A B Kimball. 2021. “Refining How We Measure As We Test: New Insights Using Adalimumab in Patients With Hidradenitis Suppurativa.”. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (12): 2342.

Flood, Kelsey S, Martina L Porter, and Alexa B Kimball. 2021. “A Visit Guide for Hidradenitis Suppurativa-Managing a Complex Disease in a Busy Clinic.”. Journal of the American Academy of Dermatology 84 (3): e155-e160.

Mehdizadeh, Ali, Afsaneh Alavi, Raed Alhusayen, Boris Bauer, Falk G Bechara, Marc Bourcier, Alain Brassard, et al. 2018. “Proceeding Report of the Symposium on Hidradenitis Suppurativa Advances (SHSA).”. Experimental Dermatology 27 (1): 104-12.

Zouboulis, C C, T Tzellos, A Kyrgidis, G B E Jemec, F G Bechara, E J Giamarellos-Bourboulis, J R Ingram, et al. 2017. “Development and Validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a Novel Dynamic Scoring System to Assess HS Severity.”. The British Journal of Dermatology 177 (5): 1401-9.